A Study of the safety and effectiveness of ARGX-113 in Patients with Primary Immune Thrombocytopenia

Update Il y a 4 ans
Reference: EUCTR2016-003038-26

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the safety and tolerability of ARGX-113.


Inclusion criteria

  • Primary Immune Thrombocytopenia